CrossRef Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management Scott Williams, Siddig Abdel Raheim, Muhammad Ilyas Khan, Umme Rubab, Prathap Kanagala, Sizheng Steven Zhao, Anne Marshall, Emily Brown, Uazman Alam Clinical Therapeutics.2022
GLP-1 receptor agonists: a novel pharmacotherapy for binge eating and bulimia nervosa
Researchers analyze its behavior in cellular models to better understand receptor activation, hormone regulation, and downstream biochemical responses
Patients using cagrlintide with tirzepatide may notice: Improved appetite suppression, leading to reduced caloric intake
Will my gabapentin dosage need to be adjusted if I start Zepbound
NAD+ is not intended to diagnose, treat, cure, or prevent any disease